Promethazine Should Not Be Used for Cough or Insomnia
Promethazine is not recommended for either cough or insomnia in adults based on current clinical guidelines. For insomnia, antihistamines like promethazine are explicitly not recommended due to lack of efficacy and safety data 1. For cough, sedating antihistamines may suppress cough but cause drowsiness and are only potentially suitable for nocturnal cough, with better alternatives available 2.
Why Promethazine Fails as Treatment
For Insomnia
The American Academy of Sleep Medicine guidelines are unequivocal: over-the-counter antihistamine drugs are not recommended for chronic insomnia treatment due to relative lack of efficacy and safety data 1. This consensus-based recommendation reflects:
- No established evidence base for sleep improvement 3
- Interference with cognitive-behavioral therapy for insomnia (CBT-I), which is the gold-standard first-line treatment
- Underappreciated addictive and recreational-use potential 3
- Unacceptable side-effect profile including next-day sedation, anticholinergic effects, and cognitive impairment 3
While older research showed promethazine increased sleep duration by approximately 1 hour 4 and suppressed REM sleep 5, these studies are outdated (1975-1986) and do not meet modern standards for insomnia treatment efficacy.
For Cough
The British Thoracic Society guidelines acknowledge that sedating antihistamines suppress cough but cause drowsiness, making them suitable only for nocturnal cough 2. However:
- Dextromethorphan is preferred over sedating antihistamines for cough suppression, with better evidence and fewer sedating effects 2
- A pediatric trial showed promethazine was no better than placebo for nocturnal cough in upper respiratory infections 6
- The cough-suppressing effect is primarily through sedation rather than specific antitussive action
What to Use Instead
For Insomnia - Follow This Algorithm:
First-line: Cognitive-behavioral therapy for insomnia (CBT-I) - most effective with minimal risk 1, 7
If pharmacotherapy needed, use this sequence:
Short-intermediate acting benzodiazepine receptor agonists (zolpidem 10 mg, eszopiclone 2-3 mg, zaleplon 10 mg) or ramelteon 8 mg 1
- These are FDA-approved with established efficacy
- Use lowest effective dose
- Reduce to 5 mg zolpidem or 1 mg eszopiclone in elderly/debilitated patients
If first agent unsuccessful: Try alternate BzRA or ramelteon
Sedating antidepressants (especially with comorbid depression/anxiety):
Dual orexin receptor antagonists (daridorexant, suvorexant) - newer evidence-based options 7
For Cough - Follow This Algorithm:
For acute viral cough:
Simple home remedies (honey and lemon) - cheapest, safest first approach 2
Dextromethorphan 60 mg - maximum cough reflex suppression, non-sedating 2
- Standard OTC doses are subtherapeutic
- Check combined preparations for other ingredients (e.g., paracetamol)
Menthol inhalation - acute, short-lived suppression 2
For nocturnal cough specifically: Sedating antihistamines may be considered, but dextromethorphan remains preferable
For chronic cough:
- Requires comprehensive assessment for underlying causes (asthma, GERD, post-nasal drip)
- Treat identified causes first
- Consider demulcents (simple linctus), then opioid derivatives if needed 8
Critical Safety Considerations
Promethazine-Specific Risks:
- Contraindicated in children under 2 years - risk of fatal respiratory depression 9
- Injectable form carries serious risks: tissue necrosis, gangrene with extravasation or intra-arterial injection 10, 11
- Respiratory depression risk, especially in combination with other CNS depressants
- Anticholinergic effects: urinary retention, confusion (especially in elderly)
- Next-day impairment affecting driving and cognitive function
FDA-Approved Dosing (if used despite recommendations):
Per FDA labeling 9:
- Sedation: 12.5-25 mg at bedtime (adults); 25-50 mg for nighttime sedation
- Allergy/cough: 25 mg at bedtime or 6.25-12.5 mg three times daily
- Not for children under 2 years
- Adjust to smallest effective dose
Common Pitfalls to Avoid
- Don't use promethazine as first-line for insomnia - it lacks guideline support and evidence
- Don't continue antihistamines long-term for sleep - tolerance develops and they interfere with proper insomnia treatment
- Don't assume cough suppression equals treatment - identify and treat underlying causes
- Don't use injectable promethazine routinely - many institutions have removed it from formularies due to safety concerns 11
- Don't combine with other CNS depressants without careful consideration of respiratory depression risk
The Bottom Line
For the patient with both cough and insomnia: Treat these as separate conditions with evidence-based therapies. Use dextromethorphan for cough suppression and a BzRA (like zolpidem) or ramelteon for insomnia if pharmacotherapy is necessary after CBT-I consideration. Promethazine offers no advantage and carries unnecessary risks for both conditions.
The continued use of promethazine for these indications represents outdated practice that should be abandoned in favor of safer, more effective alternatives with stronger evidence bases 3, 11.